170 related articles for article (PubMed ID: 20679509)
21. In Vitro Activity of Rifampicin Combined with Daptomycin or Tigecycline on Staphylococcus haemolyticus Biofilms.
Szczuka E; Grabska K; Kaznowski A
Curr Microbiol; 2015 Aug; 71(2):184-9. PubMed ID: 25894996
[TBL] [Abstract][Full Text] [Related]
22. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
Smith K; Perez A; Ramage G; Gemmell CG; Lang S
Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
[TBL] [Abstract][Full Text] [Related]
23. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
[TBL] [Abstract][Full Text] [Related]
24. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
[TBL] [Abstract][Full Text] [Related]
25. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
[TBL] [Abstract][Full Text] [Related]
26. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.
Aybar Y; Ozaras R; Besirli K; Engin E; Karabulut E; Salihoglu T; Mete B; Tabak F; Mert A; Tahan G; Yilmaz MH; Ozturk R
Int J Antimicrob Agents; 2012 Apr; 39(4):338-42. PubMed ID: 22364717
[TBL] [Abstract][Full Text] [Related]
28. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
[TBL] [Abstract][Full Text] [Related]
29. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
[TBL] [Abstract][Full Text] [Related]
30. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of daptomycin combined with fosfomycin or rifampin on planktonic and adherent linezolid-resistant isolates of Enterococcus faecalis.
Zheng JX; Sun X; Lin ZW; Qi GB; Tu HP; Wu Y; Jiang SB; Chen Z; Deng QW; Qu D; Yu ZJ
J Med Microbiol; 2019 Mar; 68(3):493-502. PubMed ID: 30882300
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
[TBL] [Abstract][Full Text] [Related]
33. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
[TBL] [Abstract][Full Text] [Related]
34. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
[TBL] [Abstract][Full Text] [Related]
35. Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.
Provinciali M; Cirioni O; Orlando F; Pierpaoli E; Barucca A; Silvestri C; Ghiselli R; Scalise A; Brescini L; Guerrieri M; Giacometti A
J Med Microbiol; 2011 Dec; 60(Pt 12):1806-1812. PubMed ID: 21835971
[TBL] [Abstract][Full Text] [Related]
36. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.
Ferreira IS; Bettencourt AF; Gonçalves LM; Kasper S; Bétrisey B; Kikhney J; Moter A; Trampuz A; Almeida AJ
Int J Nanomedicine; 2015; 10():4351-66. PubMed ID: 26185439
[TBL] [Abstract][Full Text] [Related]
37. Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
Poonacha N; Nair S; Desai S; Tuppad D; Hiremath D; Mohan T; Vipra A; Sharma U
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559263
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo.
Shi J; Mao NF; Wang L; Zhang HB; Chen Q; Liu H; Tang X; Jin T; Zhu CT; Li FB; Sun LH; Xu XM; Xu YQ
PLoS One; 2014; 9(12):e113133. PubMed ID: 25551618
[TBL] [Abstract][Full Text] [Related]
39. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Edmiston CE; Goheen MP; Seabrook GR; Johnson CP; Lewis BD; Brown KR; Towne JB
Am J Surg; 2006 Sep; 192(3):344-54. PubMed ID: 16920429
[TBL] [Abstract][Full Text] [Related]
40. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
